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The search for cancer treatment continues to be a global effort. As part of this effort, many natural products have been tested against 
various types of cancer cell lines1 and still there has been a long standing interest in the identification of medicinal plants and derived natural 
products for developing cancer therapeutics.2 India has one of the richest plant medical traditions in the world and around 25,000 effective plant-
based formulations used in ethanobotanical communities in India. But only a small portion has been explored phytochemically.3 Therefore, the 
search for alternative drugs that are both effective and non-toxic in the treatment of cancers is an important research line.4 In fact, increased 
efforts are being made to isolate the bioactive products from medicinal plants for their possible utility in cancer treatment.5 The National Cancer 
Institute (NCI) alone has reportedly screened more than 120,000 plant extracts from 35,000 species for isolation and characterization of novel 
anticancer phytocompounds.6, 7 Hartwell, in his review of plants used against cancer, lists more than 3000 plant species that have reportedly been 
used in the treatment of cancer.8Moreover, from 252 drugs considered as basic and essential by the World Health Organization (WHO), 11% are 
exclusively derived from plants and there are a noteworthy number of drugs that were obtained by molecular modification of natural products.9 
Hence, for some decades traditionally used plants are gaining more attention in searching of bioactive compounds with described properties.10 A 
focused research will not only achieve definitive knowledge about the plant and its biological properties but also it may facilitate the synthesis of 
more potent drugs with reduced toxicity and better efficacy.11Subsequently there is always a need to screen a number of plants with medicinal 
value for promising biological activity.12 To make best use of traditional knowledge about anticancer properties of medicinal plants a systematic 
study is required which involves (1) Screening of medicinal plants known for anticancer property. (2) Selection of one among them possessing 
promising anticancer activity. (3) Bioassay guided isolation and identification of active principles as well as subsequent determination of the 
spectra and potency of the isolated compounds.13 Hence, the present study aims to investigate the therapeutic properties of a library of the 
selected medicinal plants (Table 1) for their potential anticancer (antiproliferative and cytotoxic) activity against human breast cancer cell lines 
viz., MDA-MB-231 and MCF-7. The selection of medicinal plants for screening was based on their ethnobotanical uses as well as reported 
anticancer properties in the literature. 
 
2. Materials and Methods 
2.1 Plant material 
Fresh, disease free leaves of 12 medicinal plants were collected from Danvantrivanna, Bangalore University campus, Bangalore, 
Karnataka, India (Table 1). The plant material was identified and authenticated by an expert taxonomist. The collected plant material was washed 
thoroughly under the running tap water in order to remove dirt, germs and other contaminants, shade dried then powdered and used for extraction. 
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Abstract 
The present study aims to investigate the therapeutic properties of a library of the medicinal plants for their potential 
anticancer activity against breast cancer cells. The viability of MDA-MB-231 and MCF-7 breast cancer cells was determined by MTT 
and trypan blue exclusion assays. The cellular cytotoxicity and levels of cytosolic enzyme, Lactate Dehydrogenase (LDH) were measured 
by assessing µmoles of NADH/well/min. Additionally DNA laddering and FACS analysis was done to further investigate the nature of 
cell death in these cells. Out of the tested plants, only Abrus precatorius L. extract showed a very significant cytotoxic activity on both 
cell lines. Trypan-blue assay showed the cell viability was significantly decreased in a dose dependant manner in both cell lines after 48 h 
of treatment. On the other hand, LDH activities in the cultured media were significantly elevated in both cell lines in a dose dependant 
manner as compared to the control. A prominent DNA laddering pattern in agarose gel was observed, which is an important hallmark of 
apoptosis. FACS analysis confirmed the apoptosis by the appearance of Sub G0/G1 peak in treated cells as compared to the control. This 
analysis will facilitate the use of traditional medicine in cancer treatment. 
Keywords: Ethanobotany, Abrus precatorius L., Breast cancer, Cytotoxicity. 
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Authenticated voucher specimens of the plants are deposited in the herbarium of Molecular Diagnostic and Nanobiotechnology Laboratories, 
Department of Microbiology and Biotechnology, Bangalore University, Bangalore for future reference14. 
 
Table 1: Medicinal plants screened against MDA-MB-231 and MCF-7 breast cancer cell lines for anticancer activity. 
 
Sl. No. Plant Species Family Common Name Voucher number 
1. Abrus precatorius L. Fabaceae Indian Liquorice BU/MKS-MDL/AP-1 
2. Bauhinia variegate L. Fabaceae Kachnar BU/MKS-MDL/BV-2 
3. Caesal piniagilliesii Fabaceae Bird of Paradise BU/MKS-MDL/CG-3 
4. Decale pishamiltonii W. Apocynaceae Swallow root BU/MKS-MDL/DH-4 
5. Emblica officinalis L. Phyllanthaceae Amla BU/MKS-MDL/EO-5 
6. Jatropha gossypiffolia L. Euphorbiaceae Physic nut BU/MKS-MDL/JG-6 
7. Moringa oleifera L. Moringaceae Moringa BU/MKS-MDL/MO-7 
8. Plumbago zeylanica L. Plumbaginaceae Plumbago BU/MKS-MDL/PZ-8 
9. Salacia oblonga L. Celastaceae Saptrangi BU/MKS-MDL/SO-9 
10. Tinospora cordifolia M. Menispermaceae Guduchi BU/MKS-MDL/TC-10 
11. Vitex negundo L. Verbenaceae Huang Ping BU/MKS-MDL/VN-11 
12. Ziziphus jujuba Mill. Rhamnaceae Jujube BU/MKS-MDL/ZJ-12 
 
2.2 Preparation of Plant Crude Extracts 
Aqueous leaf extracts of 12 medicinal plants were prepared by the process of maceration.15 Dried plant sample was grinded to fine 
powder in mixer-grinder and sieved. The powder of each sample was suspended in double distilled water at the rate of 10 gms in 60 ml, sonicated 
for 15 minutes and mixed with magnetic stirrer for overnight. Each extract was passed through two layered cheese cloth.16The filtrate was then 
centrifuged at 5,000 rpm for 30 min. Lyophilization of the mother solution was done with a Speedvac (Savant Speedvac SC100 Centrifugal 
Evaporator, USA). Lyophilized aqueous extracts were dissolved in PBS (sterile) to a stock concentration of 50 mg/ml and then passed through a 
0.2 µm filter (Sartorius Stedim) for sterilization and was then used for cytotoxicity assays. 
2.3 Cell Lines and Culturing of cells 
Human breast cancer cell lines MDA-MB-231 and MCF-7 cells were procured from Indian Institute of Science (IISc), Bangalore 
(India). Cells were maintained in Dulbecco's Modiﬁed Eagle's medium (DMEM) with 10% FBS, 100 U/ml penicillin and 100 μg/ml 
streptomycin, in a humidified atmosphere of 95% air and 5% CO2 at 37°C. Once the cells had covered about 80% of the surface, they were 
trypsinized and the titer was adjusted using haemocytometer for antiproliferative and cytotoxicity measurements.17 
2.4 Analyses of Cell viability of Selected Medicinal Plants by MTT Assay 
To evaluate in vitro antiproliferative and/or cytotoxic activity of 12 medicinal plants listed in table 1,standard colorimetric MTT (3-(4, 
5- dimetylthiazol-2-yl)-2,5 diphenyltetrazolium bromide) assay was done.18MDA-MB-231 and MCF-7 cells (5x103 cells/well) were seeded to 96-
well microtiter plates (Falcon, Becton Dickinson, NJ). After 24 hours of plating, cells were serum starved for 24 hours. Respective concentrations 
of all extracts were added in serum free medium and 0.2 % (v/v) DMSO (Merck Germany) as negative control. After 48 h of treatment, 50 μl of 
MTT (2 µg/ml) reagent (Sigma, St. Louis, MO), was added to each well. The plates were incubated at 370C in humidified atmosphere with 5% 
CO2 for 4 h. Medium was removed and 200 µl DMSO was added.
19 The absorbance at 595 nm was measured using a Model 680 Microplate 
Reader (Bio-Rad Laboratories, Inc. USA). The percentage of cell viability was calculated according to the following equation.  20 Percentage of 
cell viability = (OD of treated cells / OD of control cells) × 100. The concentration of drug that inhibits 50% of the cells (IC50 values) for these 
samples were obtained from dose-response curves. 
2.5. Trypan Blue Exclusion Assay for Cell Viability 
For the determination of cell viability, MDA-MB-231 and MCF-7 breast cancer cells were plated at a density of (1 × 106 cells/well) in 
24 well tissue culture plate and cultured for 48 hours at 370C. The medium was replaced with serum-free medium and the cells were treated with 
various concentrations of A. precatorius leaf extract (50, 100, 200, 500 and 750 μg/mL) for a further 48 hours. The cultures were harvested and 
washed twice with PBS, the cell pellet was then suspended with 0.5 ml PBS. Then 20 μl of cell was mixed with equal volume of 0.4 % trypan 
blue (Sigma-Aldrich, USA). Cells with an intact membrane are able to exclude the dye, while membrane damaged cells after exposure with 
extract uptake trypan blue and become blue cells.21Number of live and dead cells was directly counted on hemocytometer under inverted 
microscope. The percentage viability for the cells was calculated as (live cells/total cells) x100. The calculated percentage of unstained cells will 
represent the percentage of viable cells. 
2.6. Lactate dehydrogenase leakage assay  
Cytotoxicity induced by leaf extract of Abrusprecatorius was assessed by lactate dehydrogenase (LDH) leakage into the culture 
medium. LDH, a cytoplasmic enzyme, release is the consequence of cell membrane rupture.22 Cell membrane rupture was defined as the ratio of 
LDH activity in the supernatant of treated cells to the LDH activity released in the control cells. MDA-MB-231 and MCF-7 breast cancer cells (1 
× 106 cells/well) were plated in 100 µL of medium/well in 96-well plates and were allowed to attach to the plate for 24 h. After cell attachment 
(24 h) cells were treated with increasing concentrations of A. precatorius leaf extract (50, 100, 200, 500 and 750 μg/mL). The extracellular LDH 
activity was measured in the medium after 24 h. Following treatment, the culture medium was aspirated and centrifuged at 3000 rpm for 5 min in 
order to obtain a cell free supernatant. The activity of LDH in the medium was determined using 100 µL of cell free supernatant of the control 
and A. precatorius treated MDA-MB-231 and MCF-7 breast cancer cells was added to 1-mL cuvette containing 0.9mL of a reaction mixture to 
yield a final concentration of 1mmol/L pyruvate, 0.15 mmol/L NADH and 104 mmol/L phosphate buffer, pH 7.4. After thoroughly mixed, the 
absorbance of the solution was measured at 340 nm for 45 s. LDH activity was expressed as μ moles of NADH used per minute per well. All 
experiments were repeated three times in triplicates. 
2.7. DNA Laddering Assay 
MDA-MB-231 and MCF-7 breast cancer cells were treated with aqueous extract of A.precatorius for 12 h. At the end of treatment, 
both adherent cells and floating cells were harvested and then treated with 100 µl lysis buffer (1% NP-40 in 20 mM EDTA, 50 mMTris-HCl, pH 
7.5). The supernatant was collected by centrifugation for 5 min at 1600 g. The supernatant was brought to 1% SDS and treated for 2 h with 
RNase-A (final concentration 5 mg/ml) at 560C followed by digestion with proteinase K (final concentration 2.5 mg/ml) for at least 2 h at 370C.23 
After addition of 1/2 volume 10 M ammonium acetate, the DNA was precipitated with 2.5 volume cold absolute ethanol. The DNA pellet was 
obtained by centrifugation at 12,000 g for 20 min at 40C, and the DNA was dissolved in TE buffer (10 mMTris-HCl, pH 8.0, 1 mM EDTA). 
Purity and quantification of the DNA were done by measuring absorbance at 280 nm. Samples (100 ng each) were mixed with loading dye 
(xylene cyanol in 30% glycerol) and resolved at 80V 2 h on a 1.5% agarose gel containing 0.5 mg/ml ethidium bromide. A 100 bp ladder DNA 
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sample was used as a marker. The resulting DNA fragmentation was visualized under UV transilluminator (UVI Pro) followed by Polaroid 
photography in gel documentation unit. 
 
2.8 Cell Cycle Analysis 
Cell cycle analysis was performed by propidium iodide (PI) based measurements of DNA content of the cells by flow cytometry. 
MDA-MB-231 and MCF-7 breast cancer cells were plated in a six well plate at the rate of 4 X 105 cells per ml and incubated for 24 hours. Both 
the cells lines were treated with aqueous extract of A.precatorius for another 24 hours. After treatment, the cells were trypsinized, washed with 
DPBS and fixed with 70% cold methanol and the mixture kept in −200C overnight. After centrifugation for 5 min at 2000rpm at 40C, the pellet 
was treated with 2mg/ml RNase-A at 370C and stained with 50 μg/ml propidium iodide.24 The sample was then subjected to FACS analysis and 
the percentage of cells in each stage of the cell cycle was determined using Cell-Quest software (Becton–Dickinson Biosciences, USA). 
2.9 Statistical Analysis 
Results were expressed as means ± SD of replicates. Comparison between data sets was performed using one way analysis of variance 
(ANOVA) followed by Student’s t-test. Differences were accepted as statistically significant at p < 0.05. 
 
3. Results 
3.1 Cytotoxicity effects of an aqueous leaf extracts of medicinal plants on breast cancer cell proliferation 
 




MTT assay of extracts (a)showing cytotoxic activity (DH-Decalepis hamiltonii, TC- Tinospora cordifolia, JG-Jatropha gossypiffolia, AP- Abrus 
precatorius), (b) without cytotoxic activity after 48 h treatment on MDA-MB-231 breast cancer cells (BV-Bauhinia variegate, CG-
Caesalpiniagilliesii, EO- Emblica officinalis, MO-Moringa oleifera, PZ-Plumba gozeylanica, SO- Salacia oblonga, VN- Vitex negundo, ZJ- 
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Figure 2: Microscopic view of MDA-MB-231 and MCF-7 cells before(a,b and e,f) and after (c,d and g,h) treatment with A. precatorius extractat 
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3.3. Assessing cellular viability by Trypan blue exclusion Assay 
 
Figure 3:Effect of leaf extract of A. precatorius on cell viability of (a) MDA-MB-231 cells (b) MCF-7 cells in a dose dependent manner as 
measured by Trypan Blue Assay. Viability decreased from 82.41% and reached a minimum value of 17.84% in MDA-MB-231 cells and in MCF-
7 cells, viability decreased from 79.60% to 14.49% at 50 and 750 µg/ml respectively. 
 





Figure 4: Effect of leaf extract of A. precatorius on the levels of cytosolic enzyme LDHreleased into the medium of the control and A. 
precatorius-treated (a) MDA-MB-231 cells (b) MCF-7 cells in a dose dependent manner. LDH level wassignificantly elevatedfrom 1.0 µmoles to 
7.83 µmoles in MDA-MB-231 cells and in MCF-7 cells was increased from 1.0 µmoles to 10.5 µmoles at 750 µg/ml of NADH/well/min. 
 
3.5 A. Precatorius induces significant DNA fragmentation in MDA-MB-231 and MCF-7 cells 
 
 
Figure 5:Agarose gel electrophoresis displaying DNA fragmentation in MDA-MB-231 and MCF-7 cells incubated with A. precatorius extract at 
104 and 90 µg/ml respectively. Marker 100 bp; Lane-1: positive control; 2: negative control; 3: Untreated MDA-MB-231; 4: Untreated MCF-7; 
5: Treated MDA-MB-231; 6: Treated MCF-7cells. 
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Figure 6: Flow cytometric analysis of the DNA histograms of PI-stained MDA-MB-231(a) and MCF-7 cells (b) treated with A. precatorius at its 
respective IC50 concentration. The percentages of cells in the indicated phases of the cell cycle are mentioned. Sub-G0/G1 peak is an indicative of 
apoptotic cells in both the cell lines. 
 
4. Discussion 
Due to the high mortality rates of the cancer and the lack of efficient chemotherapy, there is a continued necessity for new alternatives 
for treatment and prevention of cancer25. Plant derived products are considered excellent sources for the discovery and development of novel 
cancer chemoprotective and chemotherapeutic drugs26. There are two main strategies for the selection of plants species in anticancer drug 
discovery: random screening and ethno-medical knowledge27. In the present study based on the ethno-botanical and ethno-pharmacological data, 
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twelve traditional Indian medicinal plants were selected for their potential anticancer (antiproliferative and cytotoxic) activity against breast 
cancer cells. Cytotoxicity screening models provide important preliminary data to help select plant extracts with potential anticancer properties28.  
In the present study cytotoxicity was determined using the standard colorimetric MTT assay. Based on this assay out of the selected 
medicinal plants, only A. precatorius showed significant activity on growth and proliferation of breast cancer cells. Previous preliminary studies 
also reported significant cytotoxic activities of various plant crude extracts on various types of breast cancer cell lines (Junior et al., 2010). 
Microscopic examination shows a significant morphological changes, such as shrinkage and detachment of cells from the surface in both cell 
lines, treated as compared to non-treated cells. Further, trypan blue exclusion assay method showed the reduction of cell viability in dose 
dependent manner in treated MDA-MB-231 cells as compared to control cells. Cytotoxicity induced by leaf extract of A. precatorius was 
assessed by lactate dehydrogenase (LDH) leakage into the culture medium. LDH, a cytoplasmic enzyme, release is the consequence of cell 
membrane rupture. Cell membrane rupture was defined as the ratio of LDH activity in the supernatant of treated cells to the LDH activity 
released in the control cells. The levels of cytosolic enzyme Lactate Dehydrogenase (LDH) was significantly elevated after 48 h of A. precatorius 
leaf extract treatment in the medium when compared to the control.One of the important hallmarks of apoptosis is DNA fragmentation. As shown 
in agarose gel electrophoresis, increased DNA fragmentation was apparent in treated MDA-MB-231 and MCF-7 cells as compared to the 
untreated cells.Flow cytometric analysis showed that A. precatoriushas a pro-apoptotic activity on both MDA-MB-231 and MCF-7 cells. A 
significant increase sub G0/G1 population of cells was analyzed from (9.14% to 42.18%) in MDA-MB-231 cells and (16.6% to 39.18%) in MCF-
7 cells after 24 h treatment, as compared to control cells. This is an important indicator of apoptosis.  
This study provides an important basis for further investigation into the isolation, identification, characterization and molecular 
mechanism behind the specific cytotoxic activity of bioactive anticancer phytochemicals present in A. precatorius and to emphasize the use of 
traditional medicine in cancer treatment. 
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